Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paricalcitol Effect on Inflammation in Hemodialysis
NCT00294866Phase 4Completed
- Sponsor
- Fresenius Medical Care
- Start
- Mar 2006
- Primary completion
- Jan 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of paricalcitol in chronic kidney disease (CKD), sponsored by Fresenius Medical Care. Started Mar 2006; status: completed.
02
Drugs
paricalcitol
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT00294866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00294866.